Ritonavir-boosted nirmatrelvir: Revision history

31 January 2025

• curprev 20:4920:49, 31 January 2025‎ Azhandos talk contribs‎ 5,438 bytes +419‎ →‎Adverse Reactions
• curprev 20:4520:45, 31 January 2025‎ Azhandos talk contribs‎ 5,019 bytes −42‎ →‎Renal Dosing
• curprev 20:4520:45, 31 January 2025‎ Azhandos talk contribs‎ 5,061 bytes +353‎ →‎Hepatic Dosing
• curprev 20:4320:43, 31 January 2025‎ Azhandos talk contribs‎ 4,708 bytes +217‎ →‎Lactation risk
• curprev 20:4220:42, 31 January 2025‎ Azhandos talk contribs‎ 4,491 bytes −53‎ →‎Adverse Reactions
• curprev 20:4120:41, 31 January 2025‎ Azhandos talk contribs‎ 4,544 bytes +416‎ →‎Pharmacology
• curprev 20:3920:39, 31 January 2025‎ Azhandos talk contribs‎ 4,128 bytes +154‎ →‎Pregnancy Rating
• curprev 20:3720:37, 31 January 2025‎ Azhandos talk contribs‎ 3,974 bytes +199‎ →‎References
• curprev 20:3620:36, 31 January 2025‎ Azhandos talk contribs‎ 3,775 bytes +276‎ →‎Mechanism of Action
• curprev 20:3520:35, 31 January 2025‎ Azhandos talk contribs‎ 3,499 bytes +343‎ →‎Paxlovid
• curprev 20:3420:34, 31 January 2025‎ Azhandos talk contribs‎ 3,156 bytes +10‎ →‎Indications
• curprev 20:3320:33, 31 January 2025‎ Azhandos talk contribs‎ 3,146 bytes +52‎ →‎Indications for and selection of COVID-19-specific therapy for adult outpatients
• curprev 20:2920:29, 31 January 2025‎ Azhandos talk contribs‎ 3,094 bytes −272‎ →‎Pediatric Dosing
• curprev 20:2920:29, 31 January 2025‎ Azhandos talk contribs‎ 3,366 bytes +302‎ →‎Dosing
• curprev 20:2820:28, 31 January 2025‎ Azhandos talk contribs‎ 3,064 bytes −300‎ →‎Pediatric Dosing
• curprev 20:2820:28, 31 January 2025‎ Azhandos talk contribs‎ 3,364 bytes +13‎ →‎Adult Dosing
• curprev 20:2820:28, 31 January 2025‎ Azhandos talk contribs‎ 3,351 bytes −91‎ →‎Administration
• curprev 20:2720:27, 31 January 2025‎ Azhandos talk contribs‎ 3,442 bytes +137‎ →‎References
• curprev 20:2620:26, 31 January 2025‎ Azhandos talk contribs‎ 3,305 bytes +1,343‎ →‎Dosing
• curprev 20:1620:16, 31 January 2025‎ Azhandos talk contribs‎ 1,962 bytes +133‎ →‎References
• curprev 20:1320:13, 31 January 2025‎ Azhandos talk contribs‎ 1,829 bytes +314‎ →‎Adult Dosing

18 January 2022

• curprev 20:2620:26, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 1,515 bytes +12‎ No edit summary
• curprev 20:2520:25, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 1,503 bytes −36‎ →‎COVID
• curprev 20:2420:24, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 1,539 bytes −109‎ →‎COVID
• curprev 20:2220:22, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 1,648 bytes +285‎ →‎Pediatric Dosing
• curprev 20:2120:21, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 1,363 bytes +284‎ →‎COVID
• curprev 20:2120:21, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 1,079 bytes −282‎ →‎Comments
• curprev 20:2020:20, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 1,361 bytes −655‎ →‎Comments
• curprev 20:2020:20, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 2,016 bytes −83‎ →‎Comments
• curprev 20:1920:19, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 2,099 bytes +1,503‎ No edit summary
• curprev 20:1820:18, 18 January 2022‎ Rossdonaldson1 talk contribs‎ m 596 bytes 0‎ Rossdonaldson1 moved page Paxlovid to Ritonavir-boosted nirmatrelvir

• curprev 20:1820:18, 18 January 2022‎ Rossdonaldson1 talk contribs‎ 596 bytes +596‎ Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: Paxlovid ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== ===Drug..."